7Baggers
Quarterly
Annual
    Unit: USD2025-09-27 2025-06-28 2025-03-29 2024-12-31 2024-09-28 2024-06-29 2024-03-30 2023-12-31 2023-09-30 2023-07-01 2023-04-01 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2021-12-31 2021-10-02 2021-07-03 2021-04-03 2020-12-31 2020-09-26 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 
      
    		                            
      cash flows from operating activities:
    		                            
      net income
    		156,000,000 -825,000,000 6,000,000 23,000,000 20,000,000 30,000,000 43,000,000 82,000,000 21,000,000 50,000,000 57,000,000 39,000,000 63,000,000 94,000,000 87,000,000 67,000,000 68,000,000 58,000,000 49,000,000 59,000,000 75,000,000 -76,000,000 -21,000,000 -9,000,000 8,000,000 -11,000,000 48,000,000 16,000,000 
      adjustments to reconcile net income to net cash in operating activities:
    		                            
      depreciation and amortization
    		49,000,000 49,000,000 47,000,000 46,000,000 46,000,000 28,000,000 24,000,000 27,000,000 22,000,000 25,000,000 24,000,000 25,000,000 24,000,000 25,000,000 20,000,000 21,000,000 22,000,000 22,000,000 23,000,000 22,000,000 22,000,000 21,000,000 21,000,000 25,000,000 19,000,000 20,000,000 16,000,000  
      restructuring, impairment and extinguishment costs
    		3,000,000   5,000,000                         
      stock-based compensation expense
    		13,000,000 15,000,000 15,000,000 15,000,000 15,000,000 15,000,000 14,000,000 8,000,000 11,000,000 13,000,000 12,000,000                  
      other
    		-9,000,000 2,000,000 6,000,000 2,000,000 -12,000,000 14,000,000 3,000,000 -16,000,000 0 0 2,000,000 -2,000,000 13,000,000 -7,000,000 2,000,000 -1,000,000 -14,000,000 -7,000,000 25,000,000 1,000,000 -1,000,000 9,000,000 12,000,000      
      changes in assets and liabilities, net of acquired companies:
    		                            
      accounts receivable
    		-16,000,000 -72,000,000 -13,000,000 61,000,000 -22,000,000 -91,000,000 34,000,000 28,000,000 26,000,000 -58,000,000 23,000,000 70,000,000 3,000,000 -84,000,000 -61,000,000 48,000,000 -45,000,000 -16,000,000 -17,000,000 37,000,000 -177,000,000 130,000,000 -17,000,000      
      inventories
    		-71,000,000 -13,000,000 17,000,000 -58,000,000 -9,000,000 -11,000,000 7,000,000 36,000,000 11,000,000 12,000,000 -27,000,000 7,000,000 -2,000,000            -14,000,000 -23,000,000 -72,000,000 -30,000,000 
      other current assets
    		-9,000,000 -35,000,000 9,000,000 -20,000,000 6,000,000 6,000,000 3,000,000 11,000,000 -8,000,000 11,000,000 -8,000,000 12,000,000 -17,000,000 -9,000,000 -12,000,000 33,000,000 18,000,000 -40,000,000 16,000,000 -10,000,000 2,000,000 3,000,000 10,000,000 -40,000,000 -5,000,000 8,000,000 -16,000,000 -23,000,000 
      accounts payable
    		-66,000,000 109,000,000 -101,000,000 65,000,000 31,000,000 75,000,000 -44,000,000 32,000,000 -58,000,000 56,000,000 -12,000,000 -48,000,000 -49,000,000 37,000,000 17,000,000 -23,000,000 -4,000,000 0 -15,000,000 61,000,000 47,000,000 -108,000,000 -1,000,000 -15,000,000 -48,000,000 -45,000,000 70,000,000 80,000,000 
      accrued liabilities
    		-70,000,000 185,000,000 -112,000,000 69,000,000 13,000,000 11,000,000 -89,000,000 80,000,000 -20,000,000 -8,000,000 -86,000,000 -29,000,000 22,000,000 19,000,000 -66,000,000 -12,000,000 36,000,000 56,000,000 -66,000,000 -17,000,000 40,000,000 88,000,000 -80,000,000 28,000,000 11,000,000 -11,000,000 -6,000,000 80,000,000 
      obligations payable under the indemnification agreement
    		-1,625,000,000                            
      net cash from operating activities
    		-1,571,000,000 200,000,000 -65,000,000 203,000,000 147,000,000 92,000,000 2,000,000 263,000,000 60,000,000 121,000,000 -4,000,000 139,000,000 37,000,000 35,000,000 -59,000,000 112,000,000 104,000,000 94,000,000 5,000,000 152,000,000 21,000,000 145,000,000 -74,000,000 93,000,000 -33,000,000 -27,000,000 -10,000,000 87,000,000 
      cash flows from investing activities:
    		                            
      acquisitions, net of cash acquired
    		   -3,000,000 0   0 -10,000,000 0 -6,000,000 -5,000,000 -27,000,000                
      capital expenditures
    		-28,000,000 -20,000,000 -31,000,000 -22,000,000 -22,000,000 -15,000,000 -21,000,000 -31,000,000 -25,000,000 -29,000,000 -20,000,000 -51,000,000 -10,000,000                
      free cash flows
    		-1,599,000,000 180,000,000 -96,000,000 181,000,000 125,000,000 77,000,000 -19,000,000 232,000,000 35,000,000 92,000,000 -24,000,000 88,000,000 27,000,000                
      other investing activities
    		   2,000,000 0 7,000,000 -1,000,000                      
      net cash from investing activities
    		-28,000,000 -20,000,000 -31,000,000 -23,000,000 -22,000,000 -1,342,000,000 -22,000,000 46,000,000 -35,000,000 -29,000,000 -26,000,000 -57,000,000 -37,000,000 -5,000,000 -665,000,000 -9,000,000 -14,000,000 -18,000,000 -24,000,000 -18,000,000 -19,000,000 -15,000,000 -51,000,000 -29,000,000 -28,000,000 -34,000,000 -21,000,000 -18,000,000 
      cash flows from financing activities:
    		                            
      proceeds from issuance of long-term debt
    		   0                         
      proceeds from issuance of preferred stock, net of issuance costs
    		   0 0                        
      repayments of long-term debt
    		-1,000,000   -3,000,000 -596,000,000 -3,000,000 -3,000,000 -3,000,000 -3,000,000 -3,000,000 -3,000,000 -3,000,000 -3,000,000                
      acquisition of treasury shares to cover stock award tax withholding
    		-7,000,000 -1,000,000 -15,000,000                          
      preferred stock dividend payments
    		-9,000,000 -8,000,000 -9,000,000                          
      other financing activities
    		11,000,000 0 2,000,000 3,000,000 -6,000,000 -2,000,000 -4,000,000 -1,000,000 2,000,000 -6,000,000 -6,000,000                  
      net cash from financing activities
    		1,192,000,000 -11,000,000 -22,000,000 -12,000,000 -9,000,000 1,060,000,000 -8,000,000 -17,000,000 -29,000,000 -9,000,000 -9,000,000 -12,000,000 -1,000,000 -6,000,000 189,000,000 -8,000,000 21,000,000 -6,000,000 13,000,000 118,000,000 -106,000,000 -108,000,000 349,000,000 -75,000,000 53,000,000 -8,000,000 -23,000,000 19,000,000 
      effect of foreign exchange rate changes on cash, cash equivalents and restricted cash
    		-1,000,000 7,000,000 3,000,000 -7,000,000 2,000,000 0 -5,000,000 -25,000,000 -9,000,000 4,000,000 6,000,000 4,000,000                 
      net decrease in cash, cash equivalents and restricted cash
    		  -115,000,000    -33,000,000    -33,000,000                  
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 693,000,000  0 0 637,000,000  0 0 329,000,000  0                
      cash, cash equivalents and restricted cash at end of period
    		-408,000,000 176,000,000 578,000,000  118,000,000 -190,000,000 604,000,000  -13,000,000 87,000,000 296,000,000  0                
      net increase in cash, cash equivalents and restricted cash
    		   161,000,000 118,000,000   267,000,000 -13,000,000   74,000,000                 
      restructuring expenses
    		  4,000,000    7,000,000                      
      obligations payable under indemnification agreements
    		  54,000,000            7,000,000 -2,000,000 3,000,000 1,000,000 -7,000,000 4,000,000         
      supplemental cash flow information:
    		                            
      interest paid, net of swaps
    		  39,000,000 21,000,000 19,000,000 16,000,000 22,000,000                      
      taxes paid, net of refunds
    		  21,000,000 46,000,000 28,000,000 60,000,000 28,000,000 19,000,000 37,000,000 48,000,000 19,000,000                  
      capital expenditures in accounts payable
    		  12,000,000 6,000,000 0 5,000,000 11,000,000 -5,000,000 -1,000,000 5,000,000 15,000,000                  
      deferred income taxes
    		                       -22,000,000    -48,000,000 
      proceeds from sale of business
    		                            
      preferred dividend payments
    		                            
      common stock repurchases
    		   0   -1,000,000 -13,000,000                     
      cash, cash equivalents and restricted cash at beginning of year
    		                            
      cash, cash equivalents and restricted cash at end of year
    		                            
      other liabilities
    		                       20,000,000 5,000,000 7,000,000 7,000,000 5,000,000 
      proceeds from issuance of incremental term loans under the a&r term b facility
    		                            
      restructuring and impairment expenses
    		       0 38,000,000                    
      proceeds from issuance of a&r term b facility
    		           0 0                
      interest paid
    		       -1,000,000 35,000,000 19,000,000 27,000,000 16,000,000 17,000,000                
      adjustments to reconcile net income to net cash from operating activities:
    		                            
      payment of debt facility issuance and modification costs
    		              -4,000,000 0 -18,000,000 0 -21,000,000          
      loss on extinguishment of debt
    		               0             
      issuance of common stock through public offering, net of issuance costs
    		                            
      share-based compensation expense
    		            14,000,000                
      changes in operating assets and liabilities, net of effect of acquisitions:
    		                            
      payments of debt facility issuance and modification costs
    		            0                
      income taxes paid
    		            50,000,000               -5,000,000 
      effect of foreign exchange rate changes on cash and cash equivalents
    		               -2,000,000 -4,000,000 1,000,000 -3,000,000 5,000,000 2,000,000 2,000,000 -8,000,000 1,000,000   1,000,000 -7,000,000 
      net increase in cash and cash equivalents and restricted cash
    		                            
      stock compensation expense
    		              11,000,000 10,000,000 10,000,000 10,000,000 9,000,000 8,000,000 7,000,000 7,000,000 7,000,000 3,000,000 8,000,000 7,000,000 7,000,000 5,000,000 
      inventories – net
    		              -66,000,000 -33,000,000 -32,000,000 2,000,000 -10,000,000 -45,000,000 6,000,000 64,000,000 -6,000,000      
      cash flows used for investing activities:
    		                            
      expenditures for property, plant, equipment and other intangibles
    		              -19,000,000 -15,000,000 -13,000,000 -16,000,000 -19,000,000 -20,000,000 -19,000,000 -15,000,000 -16,000,000      
      cash paid for acquisitions, net of cash acquired
    		              -633,000,000 0 -1,000,000 -5,000,000 -5,000,000 0 0 0 -35,000,000 0 0 -11,000,000 -6,000,000  
      proceeds from long-term debt
    		              200,000,000 0 300,000,000 0 950,000,000          
      repayment of long-term debt
    		              -3,000,000 -3,000,000 -262,000,000 -2,000,000 -921,000,000 -11,000,000 -5,000,000   -11,000,000 0 -5,000,000 -6,000,000  
      net decrease in cash and cash equivalents
    		              -535,000,000              
      cash and cash equivalents at beginning of period
    		              779,000,000  0 0 517,000,000 0 0 0 122,000,000 0 0 0 265,000,000 0 
      cash and cash equivalents at end of period
    		              244,000,000  107,000,000 71,000,000 508,000,000 257,000,000 -102,000,000 24,000,000 338,000,000 -10,000,000 -10,000,000 -70,000,000 212,000,000 81,000,000 
      other assets
    		                       -9,000,000 2,000,000 -7,000,000 -1,000,000 2,000,000 
      issuance of common stock through public offering, net of issuance cost
    		                            
      net increase in cash and cash equivalents
    		               93,000,000 107,000,000 71,000,000 -9,000,000 257,000,000 -102,000,000 24,000,000 216,000,000 -10,000,000 -10,000,000 -70,000,000 -53,000,000 81,000,000 
      cash and cash equivalents at beginning of year
    		                            
      cash and cash equivalents at end of year
    		                            
      net proceeds from revolving credit facility
    		                    -100,000,000 -100,000,000 350,000,000      
      cash flows from for investing activities:
    		                            
      distribution to honeywell in connection with spin-off
    		                            
      net increase in invested equity
    		                            
      non-operating obligations from honeywell
    		                            
      restructuring charges, net of payments
    		                    -2,000,000 1,000,000 5,000,000      
      changes in assets and liabilities:
    		                            
      non-operating obligations paid to honeywell
    		                    -1,000,000    -6,000,000 -3,000,000 -15,000,000  
      tax payments related to stock vestings
    		                    0 -1,000,000 -1,000,000  -1,000,000 0 -2,000,000  
      obligations payable to honeywell under indemnification agreements
    		                            
      cash flows used for operating activities:
    		                            
      obligations payable to honeywell
    		                      -2,000,000 14,000,000 -1,000,000 1,000,000 -49,000,000  
      accounts receivables
    		                            
      expenditures for property, plant, equipment and software
    		                       -29,000,000 -28,000,000 -23,000,000 -15,000,000  
      repositioning charges, net of payments
    		                        -2,000,000    
      other noncash expense
    		                        7,000,000 3,000,000 3,000,000  
      accounts, notes and other receivables
    		                        -20,000,000 10,000,000 -17,000,000 -51,000,000 
      proceeds received related to amounts due from related parties
    		                           0 
      payments related to amounts due to related parties
    		                            
      net decrease in invested equity
    		                            
      cashflow provided by cash pooling
    		                            
      cash flows used for financing activities:
    		                            
      cashflow used by cash pooling
    		                            
      net cash flow used by cash pooling
    		                            
      depreciation
    		                           5,000,000 
      amortization
    		                           12,000,000 
      repositioning charges
    		                            
      net payments for repositioning charges
    		                            
      pension expense
    		                           1,000,000 
      pension obligations
    		                            
      expenditures for property, plant and equipment
    		                           -1,000,000 
      expenditures for software
    		                            
      payments related to amounts due from related parties
    		                            
      payment of debt issuance costs
    		                            
      payment of revolving credit facility fees
    		                            
      net cash flow from (used by) cash pooling
    		                            
      repositioning
    		                            
      net payments for repositioning
    		                            
      bad debt expense
    		                            
      cash flows used in investing activities:
    		                            
      issuance related to amounts due from related parties
    		                            
      cash flows used in financing activities:
    		                            
      net (decrease) in invested equity
    		                            
      proceeds received related to amounts due to related parties
    		                            
      net cash flows from cash pooling
    		                            
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.